Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Magnetic fossils may reveal ancient creature's internal 'GPS system'- Spots to Go Hang Floating
- Dave Coulier shares new cancer diagnosis 1 year after revealing previous diagnosis
- UN panel says Israel operating 'de facto policy of torture'
- BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- Forget 'Outer Banks.' These Gen Z-ers just want to watch 'M*A*S*H*' and 'Gilmore Girls.'
- Comet C/2025 K1 (ATLAS) breaks apart in incredible telescope photos
- From candy cane fishing to ornament switcharoo, here are some of the best games you can play with your loved ones this holiday season
- The Best Internet based Courses for Expertise Improvement
